BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33191640)

  • 1. Evaluation of the prognostic potential of EGFL7 in pilocytic astrocytomas.
    Brunhara BB; Becker AP; Neder L; Gonçalves PG; de Oliveira C; Clara CA; Reis RM; Bidinotto LT
    Neuropathology; 2021 Feb; 41(1):21-28. PubMed ID: 33191640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
    Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.
    Cykowski MD; Allen RA; Kanaly AC; Fung KM; Marshall R; Perry A; Stolzenberg ED; Dunn ST
    J Neurooncol; 2013 Dec; 115(3):477-86. PubMed ID: 24057326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults.
    Hasselblatt M; Riesmeier B; Lechtape B; Brentrup A; Stummer W; Albert FK; Sepehrnia A; Ebel H; Gerss J; Paulus W
    Neuropathol Appl Neurobiol; 2011 Dec; 37(7):803-6. PubMed ID: 21696415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
    Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
    Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas.
    Appay R; Fina F; Macagno N; Padovani L; Colin C; Barets D; Ordioni J; Scavarda D; Giangaspero F; Badiali M; Korshunov A; M Pfister S; T W Jones D; Figarella-Branger D
    Mod Pathol; 2018 Oct; 31(10):1490-1501. PubMed ID: 29802359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.
    Roth JJ; Fierst TM; Waanders AJ; Yimei L; Biegel JA; Santi M
    J Neuropathol Exp Neurol; 2016 Apr; 75(4):306-15. PubMed ID: 26945035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution.
    Colin C; Padovani L; Chappé C; Mercurio S; Scavarda D; Loundou A; Frassineti F; André N; Bouvier C; Korshunov A; Lena G; Figarella-Branger D
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):693-705. PubMed ID: 23278243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma.
    Pathak P; Kumar A; Jha P; Purkait S; Faruq M; Suri A; Suri V; Sharma MC; Sarkar C
    Brain Pathol; 2017 Sep; 27(5):580-589. PubMed ID: 27608415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of disseminated pilocytic astrocytomas.
    Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
    Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
    Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult pilocytic astrocytomas: clinical features and molecular analysis.
    Theeler BJ; Ellezam B; Sadighi ZS; Mehta V; Tran MD; Adesina AM; Bruner JM; Puduvalli VK
    Neuro Oncol; 2014 Jun; 16(6):841-7. PubMed ID: 24470550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilocytic astrocytoma: a disease with evolving molecular heterogeneity.
    Sadighi Z; Slopis J
    J Child Neurol; 2013 May; 28(5):625-32. PubMed ID: 23439714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Methylthioadenosine Phosphorylase (MTAP) in Pilocytic Astrocytomas.
    Becker AP; Scapulatempo-Neto C; Menezes WP; Clara C; Machado HR; Oliveira RS; Neder L; Reis RM
    Pathobiology; 2015; 82(2):84-9. PubMed ID: 26088413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma.
    Bar EE; Lin A; Tihan T; Burger PC; Eberhart CG
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):878-87. PubMed ID: 18716556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
    Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
    Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas.
    Jeyapalan JN; Doctor GT; Jones TA; Alberman SN; Tep A; Haria CM; Schwalbe EC; Morley IC; Hill AA; LeCain M; Ottaviani D; Clifford SC; Qaddoumi I; Tatevossian RG; Ellison DW; Sheer D
    Acta Neuropathol Commun; 2016 May; 4(1):54. PubMed ID: 27229157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene.
    Sievert AJ; Jackson EM; Gai X; Hakonarson H; Judkins AR; Resnick AC; Sutton LN; Storm PB; Shaikh TH; Biegel JA
    Brain Pathol; 2009 Jul; 19(3):449-58. PubMed ID: 19016743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.
    Jeuken JW; Wesseling P
    J Pathol; 2010 Dec; 222(4):324-8. PubMed ID: 20976706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum.
    Faulkner C; Ellis HP; Shaw A; Penman C; Palmer A; Wragg C; Greenslade M; Haynes HR; Williams H; Lowis S; White P; Williams M; Capper D; Kurian KM
    J Neuropathol Exp Neurol; 2015 Sep; 74(9):867-72. PubMed ID: 26222501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.